Evaluation of cytomegalovirus infection/disease in IgG positive renal transplantation recipients on valaciclovir prophylaxis

The reactivation of CMV (Cytomegalovirus) in renal transplant recipients may be manifested across a clinical spectrum from asymptomatic viraemia to organ rejection. The purpose of this study is to evaluate the patients who have experienced CMV infection after renal transplantation in the last twelve...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of infection in developing countries 2022-12, Vol.16 (12), p.1921-1927
Hauptverfasser:	Sari, Tugba, Dursun, Belda, Ceri, Mevlut, Ergin, Cagri, Turgut, Huseyin, Ozban, Murat
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Cytomegalovirus Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - prevention & control Disease prevention Ganciclovir - therapeutic use Humans Immunoglobulin G Infections Kidney Transplantation - adverse effects Kidney transplants Retrospective Studies Valacyclovir - therapeutic use Valganciclovir - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!